AzTrials
AzTrials

Musculoskeletal DisorderNSACNCT05310695

A Multicentre Randomised Controlled Trial of the Norwegian Health in Work Service. The NSAC Efficacy Study

A study testing NSAC - rapid and NSAC - ordinary in people with Musculoskeletal Disorder and Anxiety Disorders, run by Nordlandssykehuset HF at 5 sites in Norway.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The Norwegian Sickness Absence Clinic (NSAC) is a publicly funded specialist outpatient health service, which is uniquely available for the work force. The overall aim of the NSAC is prevention of sickness absence, promote return to work (RTW) among those on sickness absence and prevent long term disability benefit… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
NSAC - rapid and NSAC - ordinary
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,500 participants
Where
5 sitesNorway
Study dates
16 Jan 2023to Oct 2034
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The patient must be considered eligible for treatment at the NSAC by the admission team at the NSAC.

Who cannot join

  • Patients considered too healthy for treatment at the NSAC, i.e. not within target group
  • Patients considered too sick for treatment at the NSAC, i.e. not within target group
  • Patients that do not have a diagnosis that is relevant for treatment at the NSAC, i.e. not within target group
  • Patients otherwise considered not within target group for the measure
  • Patients which were included in the NSAC Nudge trial (clinicaltrials identifier: NCT05006976) may not be recruited within the first year of follow-up of that trial
  • Patients which are secondary referred from other departments/clinics within the hospital
  • Non-Norwegian or non-English speaking patients
  • Patients which could not be reached by the research coordinator at the outpatient clinic for information about the study

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

Norway5 sites
  • Helsepartner Rehabilitering Alta

    Alta, Troms Og Finnmark, 9510

  • Helse I Arbeid Nordlandssykehuset

    Bodø, Nordland, 8092

  • Helse I Arbeid Finnmarkssykehuset

    Kirkenes, Troms Og Finnmark, 9915

  • Helse I Arbeid Helgelandssykehuset

    Sandnessjøen, Nordland, 8800

  • Helse I Arbeid Universitetssykehuset Nord-Norge

    Tromsø, Troms Og Finnmark, 9019

Other trials in Norway

About this study

Official title: A Multicentre Randomised Controlled Trial of the Norwegian Health in Work Service for Patients With Common Mental Disorders and Musculoskeletal Disorders: The Norwegian Sickness Absence Clinic (NSAC) Efficacy Study

The Norwegian Sickness Absence Clinic (NSAC) is a publicly funded specialist outpatient health service, which is uniquely available for the work force. The overall aim of the NSAC is prevention of sickness absence, promote return to work (RTW) among those on sickness absence and prevent long term disability benefit dependency. In addition to being a health service, the NSAC has a focus on work and functional recovery, including also non-health related factors. Patients can be referred by general practitioners for mental health problems and musculoskeletal problems. The NSAC has a lower threshold for severity than specialist health services generally, and in particular for mental health problems. The efficacy of this service is unknown.

The NSAC Efficacy Study is a randomized controlled multicentre trial which aims to assess the effect of the NSAC service. "Helse i Arbeid" is the Norwegian name for NSAC, and the Norwegian abbreviation is "HiA". The Norwegian study name is HIANOR.

Read more

The NSAC Efficacy Study involves five different NSACs across northern Norway, and will recruit 2500 patients, randomized to in equal proportions to three treatment arms:

  1. NSAC - rapid: treatment at the NSAC at- or within 4 weeks
  2. NSAC - ordinary: treatment at the NSAC after 10-14 weeks
  3. NSAC - active control: monodisciplinary examination at the NSAC close to diagnosis-specific deadline for examination as suggested by guidelines (8-26 weeks, the majority at the end of this interval) The overall aim is to assess the effect of the NSAC service, with the hypothesis that the NSAC service is superior to what resembles treatment as usual (TAU) for outcomes such as return to work or improved health (waiting list control). Many of the diagnoses or problems for which patients are referred to the NSACs naturally improve regardless of health interventions, and - as of date - no research has been conducted to assess the efficacy of the service.
Read the detailed description

The Norwegian Sickness Absence Clinic (NSAC) is a publicly funded specialist outpatient health service, which is uniquely available for the work force. The overall aim of the NSAC is prevention of sickness absence, promote return to work (RTW) among those on sickness absence and prevent long term disability benefit dependency. In addition to being a health service, the NSAC has a focus on work and functional recovery, including also non-health related factors. Patients can be referred by general practitioners for mental health problems and musculoskeletal problems. The NSAC has a lower threshold for severity than specialist health services generally, and in particular for mental health problems. The efficacy of this service is unknown.

The NSAC Efficacy Study is part of a broader project, the Norwegian Sickness Absence Clinic Study (NSACS). The NSACS currently has two sources of funding: Northern Norway Regional Health Authority and The Norwegian Labour and Welfare Administration and involves two RCTs: NSAC Efficacy and NSAC Nudge and fifteen work packages concerning health economics, scalability, implementation, profiling of patient groups, and non-RCT related research questions to improve understanding of the patient group and their challenges. To do this the project will use patient survey data, clinician-reported procedures, opinions and outcomes, linked to registry data for work benefits and health service use. The randomized controlled trial NSAC Efficacy is the subject of this trial registration.

The NSAC Efficacy Study is a naturalistic randomized controlled multicentre trial, carried out in northern Norway and involving five NSACs. The study invites 2500 patients, randomized to either of three treatment arms:

  1. NSAC rapid: treatment at the NSAC at- or within 4 weeks
  2. NSAC ordinary: treatment at the NSAC after 10-14 weeks
  3. NSAC - active control: monodisciplinary examination at the NSAC close to diagnosis-specific deadline for examination as suggested by guidelines (8-26 weeks, the majority at the end of this interval)

The NSACs are staffed by teams of medical doctors specializing in physical medicine and rehabilitation, psychologists, physiotherapists, and employment counsellors with experience from case management in the Norwegian Labor and Welfare Administration (NAV).

All patients are asked to complete an electronic survey about their mental health and musculoskeletal pain, work conditions, motivation for work and barriers for return to work (RTW). The control group only completes the survey on health, and only on either mental health or musculoskeletal pain, according to referral diagnosis.

The survey tool manages the randomization algorithm.

The NSAC is a relatively new clinical service, available for the labour force, and publicly funded with the intention to reduce sickness absence and prevent retirement from the labour force and transitions to disability benefits. The NSAC clinic welcomes patients with the most common diagnoses for sickness absence and is supposed to have a low threshold.

There is no single alternative clinical service for similar patients outside the labour force, thus no single treatment as usual (TAU) alternative. Service availability will depend on diagnosis and severity:

  • The majority of patients eligible for treatment in the NSAC referred with mental disorders would not be eligible for treatment in specialist psychiatric services as conditions in most cases would be too mild. The most common treatment alternative would be treatment at the general practitioners.
  • For patients referred for musculoskeletal problems, some may be eligible for consultations and treatment at physical medicine and rehabilitation outpatient clinics. For those not eligible, the general practitioner is the most common alternative, and other options such as private physiotherapists. Eligibility criteria may vary between catchment areas.
  • All alternatives to the NSAC would be without employment counsellors, little cross disciplinary assessment, and little to no focus on work and functional rehabilitation.

The active control group aims to be comparable to TAU, and differs from the NSAC in the following respects:

  1. Patients receive a monodisciplinary examination from either a doctor, physiotherapist of psychologist at the NSAC. The focus of the examination is on health-related factors. The patients will not receive further follow-up at the clinic beyond the first examination. Upon indication, the patient is referred to other treatment or examination outside of the NSAC.
  2. Employment counsellors are not involved in patient consultations or in discussions about patients.
  3. Patients in the active control group will not be posed questions concerning work, motivation for work or barriers for return to work. Patients will during registration in Tivian be classified as having predominantly either musculoskeletal- or common mental disorders, and this will dictate the type of questions posed: musculoskeletal patients will be asked questions on musculoskeletal factors but not psychological factors, while patients will common mental disorders will be asked questions about psychological factors but not musculoskeletal issues. For patients being examined by a psychologist, if issues concerning musculoskeletal health arise, the patient is asked to discuss these with his/her GP. If issues concerning mental health arise which requires competence beyond what the physiotherapist possesses, the physiotherapist may confer with the medical doctor at NSAC.
  4. The clinician is not to take initiative to discussing work-related factors with the patient, and as far as possible avoid these becoming central topics of the consultation. If the patient on his/her own initiative brings up such topics, the clinician is not restricted from addressing them.
  5. Employment counsellors are not part of patient discussions prior to examination.
  6. Meetings or discussions about patients are kept within profession; i.e. a physiotherapist is allowed to discuss his/her patient with other physiotherapists if need be.

The data necessary to answer the research questions are gathered from national registries via personal identifier, registry data on population level, questionnaires filled out by the patient (data on health and working conditions) and questionnaires filled out by the clinician (data on number of treatments, diagnosis, professions involved, and types of treatment provided).

The patient questionnaire covers 9 themes, split in two sections. Section 1 covers health, and includes musculoskeletal problems, mental health, and other health related issues (such as alcohol consumption, medication, and physical activity). Section 2 includes working conditions (including inter alia questions on social support, work/family conflict and bullying), barriers for RTW, labour market affiliation, other personal aspects (such as demography and motivation for work), questionnaires for health economic evaluation (such as the EQ-5D) and expectations for treatment.

By and large the questionnaire consists of test batteries which have been validated for specific topics. To reduce the number of questions posed to each patient, the baseline questionnaire will employ index questions which have proven psychometric properties in terms of factor loading or similar, meaning that if a problem on a specific topic such as neck pain is not indicated, the patient will not be presented with the Neck Disability Index questionnaire. The patient questionnaires will be filled out electronically at before first treatment and at 6- and 12 months after first treatment. In addition, before treatments, patients will be given shorter versions of the same questionnaire to be filled out at the clinic. These shorter questionnaires will consist of questions to which the patient at baseline indicated a high score, and thus includes more relevant information to the clinician.

In the NSAC Efficacy Study, receiving treatment at NSACs presupposes consent to participate in research, as the effect of the treatment is as of date unknown. Hence, receiving treatment at the NSAC is not necessarily superior to other available health services. Other available health services that may be utilized by patients serving in the control groups include mono-disciplinary treatment by physiotherapists, psychologists, general practitioners, gyms, electronically delivered self-help tools etc. All patients referred to NSACs will be offered treatment, but patients that decline to participate in research are provided an examination in line with randomization arm #3.

Being tested
NSAC - rapid, NSAC - ordinary, NSAC - active control
Keywords
Return to work, Sickness absence, Nudge, Barriers for return to work, Motivation for work, Demand and control, Work/family conflict, Bullying
Medical subject headings
Musculoskeletal Diseases, Anxiety Disorders, Depression, Fatigue, Pain, Occupational Stress, Bullying

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NSAC - rapidOther

    NSAC is an outpatient service delivered under the auspices of the specialist health care sector to patients currently on sick leave or at risk for long-term sickness absence. The service is staffed by medical doctors specialising in muskuloskeletal health, physiotherapists, psychologists and welfare sector counsellors, and aims to provide patients with a multi-diciplinary clarification or treatment of problems with the intent of improved function and return to work. Clinicians are provided survey information on the patients potential health problems, motivation for work, barriers for return to work and work environment prior to consultation. In this intervention arm, patients are offered treatment within 4 weeks of referral.

  • NSAC - ordinaryOther

    NSAC is an outpatient service delivered under the auspices of the specialist health care sector to patients currently on sick leave or at risk for long-term sickness absence. The service is staffed by medical doctors specialising in muskuloskeletal health, physiotherapists, psychologists and welfare sector counsellors, and aims to provide patients with a multi-diciplinary clarification or treatment of problems with the intent of improved function and return to work. Clinicians are provided survey information on the patients potential health problems, motivation for work, barriers for return to work and work environment prior to consultation. In this intervention arm, patients are offered treatment at 10-14 weeks after referral.

  • NSAC - active controlOther

    The active control intervention is provided by the NSAC personnel, but patients are offered a single monodisciplinary examination close to the end of the diagnosis-specific deadline suggested in guidelines, which will vary between 8-26 weeks. Employment counsellors may not be involved in consultations, other cross-disciplinary consultations are restricted, and work-related factors are not to be focused on during examination. Clinicians are provided survey information only on the patient's potential health problems prior to consultation. Patients are provided a health-focused examination, with the aim of symptom-relief.

Study groups in NCT05310695
Study groupRoleWhat they receive
NSAC rapid: treatment at the NSAC at- or within 4 weeksActive comparatorNSAC service delivered according to ordinary procedures, 4 weeks after referral.
Receives: Other: NSAC - rapid
NSAC ordinary: treatment at the NSAC after 10-14 weeksActive comparatorNSAC service delivered according to ordinary procedures, 10-14 weeks after referral, by and large equivalent to current waiting time
Receives: Other: NSAC - ordinary
NSAC - active controlActive comparatorMonodisciplinary examination at the NSAC close to diagnosis-specific deadline for examination as suggested by guidelines (8-26 weeks, the majority at the end of this interval)
Receives: Other: NSAC - active control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional recovery: employment

    Employment during first 365 days post baseline survey, based on registry data and self-report.

    Measured: 12 months post baseline survey

  2. Functional recovery: sickness absence

    Sickness absence during first 365 days post baseline survey, based on registry data and self-report.

    Measured: 12 months post baseline survey

  3. Functional recovery: application for rehabilitation benefits

    Application for rehabilitation benefits during first 365 days post baseline survey, based on registry data and self-report.

    Measured: 12 months post baseline survey

  4. Functional recovery: employment long term

    Employment during 5-and 10-year period post baseline survey, all based on registry data.

    Measured: 5 and 10 years post baseline survey

  5. Functional recovery: sickness absence long term

    Sickness absence during 5-and 10-year period post baseline survey, all based on registry data.

    Measured: 5 and 10 years post baseline survey

  6. Functional recovery: rehabilitation benefits long term

    Rehabilitation benefits during 5-and 10-year period post baseline survey, all based on registry data.

    Measured: 5 and 10 years post baseline survey

  7. Functional recovery: disability benefits long term

    Disability benefits during 5-and 10-year period post baseline survey, all based on registry data.

    Measured: 5 and 10 years post baseline survey

Secondary outcomes (15)
  1. Mental health

    Changes in self-reported mental health between baseline survey and 6- and 12 months post baseline survey, measured using the Hopkins Symptoms Checklist - 10 (HSCL-10).

    Measured: 12 months post baseline survey

  2. Anxiety

    Changes in self-reported anxiety between baseline survey and 6- and 12 months post baseline survey, measured using the Beck Anxiety Inventory (BAI). The instrument is provided to patients upon indication, defined as a HSCL-10 score > 1.4

    Measured: 12 months post baseline survey

  3. Depressive symptoms

    Changes in self-reported depression between baseline survey and 6- and 12 months post baseline survey, measured using the Beck Depression Inventory (BDI). The instrument is provided to patients upon indication, defined as a HSCL-10 score > 1.4

    Measured: 12 months post baseline survey

  4. Sleep

    Changes in self-reported sleep between baseline survey and 6- and 12 months post baseline survey, measured using 3 questions commonly used to diagnose sleeping disorder according to the DSM-IV criteria for insomnia.

    Measured: 12 months post baseline survey

  5. Health Anxiety

    Changes in self-reported health anxiety between baseline survey and 6- and 12 months post baseline survey, measured using the Whitely Index. All patients are asked the first question in the test battery, and the entire instrument is provided to patients with a score of >3 on this question

    Measured: 12 months post baseline survey

  6. Subjective health complaints

    Changes in subjective healthbetween baseline survey and 6- and 12 months post baseline survey, measured using a modified version of the Ursin Health Inventory.

    Measured: 12 months post baseline survey

  7. Back pain

    Changes in self-reported back pain between baseline survey and 6- and 12 months post baseline survey, measured using the Oswestry Disability Index (ODI). All patients are asked whether they suffer from musculoskeletal pain, and if present, they are provided questions on localization of pain. In case of back pain, patients are provided the ODI.

    Measured: 12 months post baseline survey

  8. Neck pain

    Changes in self-reported neck pain between baseline survey and 6- and 12 months post baseline survey, measured using the Neck Disability Index (NDI). All patients are asked whether they suffer from musculoskeletal pain, and if present, they are provided questions on localization of pain. In case of neck pain, patients are provided the NDI.

    Measured: 12 months post baseline survey

  9. Pain intensity

    Changes in self-reported pain intensity between baseline survey and 6- and 12 months post baseline survey, measured using a visual analogue scale scored between 0 and 10. All patients are asked whether they suffer from musculoskeletal pain, and if present, they are provided questions on pain intensity during rest and activity.

    Measured: 12 months post baseline survey

  10. Fear avoidance

    Changes in self-reported fear avoidance between baseline survey and 6- and 12 months post baseline survey, measured using the Fear Avoidance Beliefs Questionnaire (FABQ). All patients are asked whether they suffer from musculoskeletal pain, and if present, they are provided the FABQ.

    Measured: 12 months post baseline survey

  11. Physical activity

    Changes in self-reported level of physical between baseline survey and 6- and 12 months post baseline survey, measured using the Saltin-Grimby Physical Activity Level Scale (SGPALS).

    Measured: 12 months post baseline survey

  12. Fatigue

    Changes in self-reported fatigue between baseline survey and 6- and 12 months post baseline survey, measured using the Fatigue Assessment Scale. All patients are asked the first question in the test battery, and the entire instrument is provided to patients with a score of ≥ 3 on this question

    Measured: 12 months post baseline survey

  13. Pain localization

    Changes in self-reported localization of pain between baseline survey and 6- and 12 months post baseline survey. All patients are asked whether they suffer from musculoskeletal pain, and if present, they are provided questions on localization of pain.

    Measured: 12 months post baseline survey

  14. Cause of pain

    Changes in self-reported cause of pain between baseline survey and 6- and 12 months post baseline survey. All patients are asked whether they suffer from musculoskeletal pain, and if present, they are provided questions on the believed cause of pain.

    Measured: 12 months post baseline survey

  15. Self-reported diagnosis

    Changes in self-reported diagnoses between baseline survey and 6- and 12 months post baseline survey. The respondent is asked whether he/she thinks they have Covid-19 sequelae, myalgic encephalomyelitis/chronic fatigue syndrome, whiplash, fibromyalgia, hypermobility, irritable bowel syndrome or food intolerance, or whether they have been diagnosed with either of these by health personnel.

    Measured: 12 months post baseline survey

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2022
  2. Study start16 Jan 2023
  3. Primary completionOct 2026 (estimated)
  4. Study completionOct 2034 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients are randomized to either of three intervention arms:
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
2,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05310695
Sponsor's protocol ID
2019/1168-XX
Acronym
NSAC
Status last verified
May 2026
First submitted
16 Mar 2022
Last updated
8 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There are no plans to share individual patient data with other researchers. At the stage of analyses, associated researchers will be provided with an anonymized data set including all relevant data to answer the research questions.

Publications

  • Aars NAP, Bardal I, Terjesen C, Hansen BO, Jerven A, Kaspersen KI, Lyngedal O, Huttepohl F, Johnsen I, Uglebakken TO, Brinchmann B, Mykletun A. Multicentre randomised controlled trial of the Norwegian health in work service for patients with common mental disorders or musculoskeletal disorders: the Norwegian Sickness Absence Clinic (NSAC) Efficacy Study. BMJ Open. 2026 May 28;16(5):e109083. doi: 10.1136/bmjopen-2025-109083.

    PubMed 42209002

Questions about this trial

What is this clinical trial studying?

A study testing NSAC - rapid and NSAC - ordinary in people with Musculoskeletal Disorder and Anxiety Disorders, run by Nordlandssykehuset HF at 5 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 8 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional recovery: employment (time frame: 12 months post baseline survey). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05310695, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in